Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Biorational Fungicides Market size was over USD 8.62 billion in 2024 and is projected to reach USD 51.85 billion by 2037, witnessing around 14.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of biorational fungicides is assessed at USD 9.7 billion.
The market for biorational fungicides has been growing steadily due to increasing awareness of environmental concerns and a shift towards sustainable agriculture practices. Farmers and growers are increasingly adopting these products to reduce their reliance on synthetic chemicals. The use of Biorational Fungicides is subject to regulations and approvals by governmental authorities in different countries to ensure their safety and efficacy.
Biorational Fungicides, also known as bio fungicides or biological fungicides, are products that contain naturally occurring microorganisms, such as beneficial bacteria, fungi, or biochemical substances, to suppress or control fungal pathogens in agriculture. These fungicides are often considered more environmentally friendly compared to traditional chemical fungicides because they are derived from natural sources or utilize mechanisms that are less harmful to non-target organisms and ecosystems.
Biorational Fungicides Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Environmental Awareness: According to a report by the Food and Agriculture Organization (FAO), agriculture accounts for 70% of global freshwater withdrawals. As environmental concerns rise, there is growing pressure on the agricultural sector to adopt sustainable practices.
- Growing Technological Advancements: The market is boosted by ongoing advancements in biorational fungicides, including improved formulations, delivery systems, and compatibility with integrated pest management (IPM) practices.
- Enhanced Product Efficacy: Research published in the Journal of Economic Entomology found that certain biorational fungicides can provide comparable or even superior efficacy compared to chemical counterparts in disease control.
Challenges
- Limited Spectrum of Activity: One of the primary challenges confronting biorational fungicides is their relatively narrow spectrum of activity compared to synthetic chemical counterparts. Many bio fungicides are effective against specific pathogens or under certain conditions, making them less versatile in disease control.
- Variable Efficacy of biorational fungicides
- Longer Application Periods of Biorational fungicides
Biorational Fungicides: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.2% |
|
Base Year Market Size (2024) |
USD 704.83 million |
|
Forecast Year Market Size (2037) |
USD 1.2 billion |
|
Regional Scope |
|
Biorational Fungicides Segmentation
Type (Agricultural, Horticultural)
The horticultural segment is estimated to gain the largest market share of 60% in the year 2037. A report highlights ongoing advancements in biorational fungicides, including innovative formulations and delivery systems optimized for horticultural applications. The horticultural segment of the Biorational Fungicides market is poised for substantial growth, driven by a combination of factors ranging from consumer preferences for safe produce to regulatory support and the need for sustainable disease management in a changing climate. As horticultural production continues to expand, biorational fungicides are emerging as a critical tool in ensuring crop health and quality while meeting the demands of both growers and consumers.
End User (Agriculture, Greenhouse, Gardening)
The gardening segment is expected to garner a significant share in the year 2037. The increasing number of individuals engaging in home gardening activities has fueled the demand for effective and environmentally friendly solutions to manage fungal diseases that can affect plants in gardens and landscapes. According to the National Gardening Association, the number of home gardeners in the United States increased by 12 million in 2020, reaching an estimated 63 million gardeners. This trend reflects a growing interest in gardening.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportBiorational Fungicides Industry – Regional Synopsis
APAC Market Forecast
The biorational fungicides market in the Asia Pacific industry is poised to hold largest revenue share of 38% by 2037. Changing climate conditions are contributing to the emergence of new disease challenges. Biorational fungicides offer sustainable solutions to adapt to these evolving threats. According to the IPCC, the Asia Pacific region is susceptible to the impacts of climate change, including altered disease patterns in crops. The Asia Pacific Biorational Fungicides market is experiencing remarkable growth due to a confluence of factors, from regulatory support to the region's diverse agricultural landscape and the need for sustainable farming practices.
North American Market Statistics
The biorational fungicides market in the North America region is projected to hold the second-largest share during the forecast period. Consumers in North America are increasingly seeking organic products, including fruits and vegetables grown with minimal synthetic chemical inputs. Biorational fungicides align with organic farming principles, making them a vital tool for organic growers. According to the Organic Trade Association, the organic food market in North America reached USD 56 billion in sales in 2020.
Companies Dominating the Biorational Fungicides Landscape
- Bayer AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Syngenta Group
- BASF SE
- Corteva Agriscience
- Isagro S.p.A.
- Certis USA
- Koppert Biological Systems
- Marrone Bio Innovations
- Valent BioSciences
- Stockton Group
In the News
- Bayer AG acquired Asklepios BioPharmaceutical, a U.S.-based gene therapy specialist, for approximately USD 4 billion. This acquisition was part of Bayer's strategic expansion into the field of cell and gene therapies.
- In one of the largest mergers in the agrochemical industry, Bayer acquired Monsanto for approximately USD 63 billion. This acquisition brought together two major players in the agricultural sector, with Monsanto's expertise in seeds and traits complementing Bayer's crop protection and chemical portfolio.
Author Credits: Rajrani Baghel
- Report ID: 5246
- Published Date: Jan 03, 2025
- Report Format: PDF, PPT
